Free tool
FAERS Monitor: Pemetrexed Disodium
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214408 or its brand name (Pemetrexed Disodium, Pemetrexed Disodium). Reports on generic versions are filed under their own applications.
Reports
3,897
Serious
3,831
98% of reports
Hospitalization
2,202
Death reported
686
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- myelosuppression454
- malignant neoplasm progression383
- anaemia196
- diarrhoea182
- nausea179
- platelet count decreased150
- death147
- rash144
- neutropenia139
- white blood cell count decreased139
- pyrexia137
- neutrophil count decreased135
- febrile neutropenia128
- renal impairment128
- vomiting125
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 25 |
| 2005 | 8 |
| 2006 | 11 |
| 2007 | 16 |
| 2008 | 13 |
| 2009 | 10 |
| 2010 | 50 |
| 2011 | 80 |
| 2012 | 115 |
| 2013 | 33 |
| 2014 | 27 |
| 2015 | 22 |
| 2016 | 41 |
| 2017 | 83 |
| 2018 | 212 |
| 2019 | 558 |
| 2020 | 484 |
| 2021 | 472 |
| 2022 | 301 |
| 2023 | 248 |
| 2024 | 364 |
| 2025 | 399 |
| 2026 | 325 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,262 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myelosuppressionSignal | 454 | 68.9 | 63.1 | 29,975 |
| malignant neoplasm progressionSignal | 383 | 20.3 | 18.4 | 7,000 |
| neutrophil count decreasedSignal | 135 | 17.9 | 15.2 | 2,139 |
| febrile neutropeniaSignal | 128 | 10.4 | 8.8 | 1,084 |
| renal impairmentSignal | 128 | 8.2 | 6.9 | 808 |
| platelet count decreasedSignal | 150 | 7.6 | 6.5 | 857 |
| white blood cell count decreasedSignal | 139 | 6.9 | 5.9 | 702 |
| anaemiaSignal | 196 | 5.6 | 4.8 | 733 |
| neutropeniaSignal | 139 | 5.5 | 4.7 | 513 |
| pyrexiaSignal | 137 | 2.1 | 1.8 | 83 |
| rash | 144 | 1.8 | 1.5 | 50 |
| diarrhoea | 182 | 1.5 | 1.3 | 33 |
| vomiting | 125 | 1.4 | 1.2 | 16 |
| nausea | 179 | 1.2 | 1.1 | 7 |
| death | 147 | 0.9 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.